Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Delix Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Delix have partnered with Cellectricon to create novel assays to measure the structural and functional plasticity effects of Delix's psychoplastogen compounds using cutting-edge technologies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 14, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Delix Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : LIB-01
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dicot Has Submitted A New Patent Application
Details : Dicot is developing the drug candidate LIB-01(formerly Libiguin), which will be a potency agent to better treat erectile dysfunction and premature ejaculation.
Product Name : LIB-01
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 17, 2022
Lead Product(s) : LIB-01
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naloxone Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Orexo Strengthens IP Rights for Overdose Rescue Drug OX124
Details : The new patent is the second US patent for OX124. Based on Orexo's innovative scalable intranasal formulation technology, OX124 is a powerful naloxone rescue medication, designed to reverse opioid overdoses, including those from synthetic opioids, such a...
Product Name : OX124
Product Type : Controlled Substance
Upfront Cash : Inapplicable
January 27, 2021
Lead Product(s) : Naloxone Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable